SNDX Operating Cash Flow
-$220.64MTTM · USD
Period ending:
SNDX FY Operating Cash FlowUSD
$29.13M-$322.98M
2011-12-312025-12-31
Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.
SNDX operating cash flow history
Cash generated from core business operations. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.
| Period ending | Operating Cash Flow (USD) |
|---|---|
| -322,980,000 | |
| -274,903,000 | |
| -160,601,000 | |
| -133,675,000 | |
| 29,131,000 | |
| -71,260,000 | |
| -50,612,000 | |
| -68,531,000 | |
| -47,371,000 | |
| -35,157,000 | |
| -2,428,000 | |
| -14,393,000 | |
| -7,295,000 | |
| -9,284,000 | |
| -10,022,000 |
Compare operating cash flow
Other companies in Health Care. Each page shows its own reporting periods and currency.
- Guardant Health Inc (GH) operating cash flow
- Bridgebio Pharma Inc (BBIO) operating cash flow
- Brightspring Health Services Inc (BTSG) operating cash flow
- Madrigal Pharmaceuticals Inc (MDGL) operating cash flow
- Ensign Group Inc (ENSG) operating cash flow
- Glaukos Corp (GKOS) operating cash flow
- Vaxcyte Inc (PCVX) operating cash flow
- Krystal Biotech Inc (KRYS) operating cash flow
All SNDX financial metrics · SNDX stock overview · How to interpret financial metrics
